Ads
related to: iqvia site portal providerget.tebra.com has been visited by 100K+ users in the past month
capterra.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider [5] The name of the modern company honors the legacy organizations. IQVIA: I (IMS Health), Q (Quintiles), and VIA (by way of).
In 2003, acquired Marketing Initiatives, a specialist in healthcare facility profile data, and Data Niche Associates, a provider of rebate validation services for Medicaid and managed care. In 2003, IMS Health sold its entire 56% stake in Cognizant and both companies are separated into two independent entities as IMS Health and Cognizant
The International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, a 2015 Swiss NGO of pharmaceutical companies and others, defined a contract research organization (CRO), specifically pertaining to clinical trials services as: [8]: 10 "A person or an organization (commercial, academic, or other) contracted by the sponsor to perform one or ...
Syneos Health is currently based in Morrisville, North Carolina. [18] The company's clinical services business specializes in providing contract research for clinical trials to pharmaceutical and biotechnology companies, [24] [25] while the company's commercial services provide marketing and medical affairs for their products.
Parexel International is an American provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. It is the second largest clinical research organization in the world and has helped develop approximately 95% of the 200 top-selling biopharmaceuticals on the ...
In June 2006, it acquired Signet Laboratories, a provider of monoclonal antibodies used in the research of cancer, infectious disease, and neurodegenerative disease, for $8.95 million. [22] In 2007, the company opened a laboratory in Shanghai, China. [23] In 2019, it opened a research and development center in Shanghai. [24]
Quintiles is the "largest global provider of clinical trials and commercial marketing services to the pharmaceutical and biotechnology industry". [5] In December 2015, Gillings retired as executive chairman of Quintiles, but remains a director. [6] According to The Sunday Times Rich List in 2019 his net worth was estimated at £1.199 billion. [7]
ePS was founded in 2001 by Lance Converse and is headquartered in Plymouth Meeting, Pennsylvania, employing 60+ clinical researchers and technologists. ePharmaSolutions' Clinical Trial Portal technology won the 2009 and 2013 Bio-IT World for “Best in Class Clinical Trial Technology” and the 2013 Microsoft Lifesciences Innovation Award ...